Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy Adults
NCT03722472
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary TB
Interventions
BIOLOGICAL:
ID93 + GLA-SE
Sponsor
Access to Advanced Health Institute (AAHI)
Collaborators
[object Object]
[object Object]